Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page, with the footer revision changing from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T15:49:58.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH content may use both “Super Intelligence” and “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-26T16:45:09.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-19T21:56:33.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:46:38.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden error with a minimal header instead of the study record content. This indicates an access issue rather than a substantive update to the page's materials.
    Difference
    18%
    Check dated 2026-09-21T22:24:53.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page footer, indicating a software release; no study details or results appear to be altered.
    Difference
    0.0%
    Check dated 2026-08-31T16:44:12.000Z thumbnail image

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.